Peters Malte 4
4 · Tango Therapeutics, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Peters Malte
DirectorPresident & CEO
Transactions
- Award
Common Stock
[F1]2026-01-08+350,000→ 367,500 total - Award
Stock Option (Right to Buy)
[F2]2026-01-08+1,650,000→ 1,650,000 totalExercise: $11.06Exp: 2036-01-08→ Common Stock (1,650,000 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable over a four-year period, with 25% vesting on January 8, 2027 and the remaining option shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Signature
/s/ Julie Fogarty, as attorney-in-fact|2026-01-12